|
Postoperative Outcomes for Rhizotomy, Balloon Ablation, and MVD |
||||
| BA |
MVD |
Rhizotomy |
Combined |
|
|
|
||||
| Hospital Length of Stay (Days) |
2.6 ± 0.4 |
5.7 ± 0.6 * |
4.3 ± 0.2 |
5.0 ± 0.3 |
| Without Complications (Days) |
0.5 ± 0.1 |
4.6 ± 0.6 |
3.3 ± 0.3 |
|
| Length of Follow-up (Months) |
21.8 ± 3.2 |
33.4 ± 7.1 |
21.0 ± 4.9 |
26.5 ± 42 |
| Incidence of Immediate Improvement in Symptoms |
56/78 (72%) |
31/34 (91%) * |
35/41 (85%) * |
66/75 (88%) |
| Improvement of Symptoms with Bradycardia |
75% |
87% |
80% |
84% |
| Incidence of Total Cure |
31/78 (40%) ** |
23/34 (68%) |
22/41 (54%) ** |
45/75 (60%) |
| Incidence of No Change in Symptoms |
21/78 (27%) |
2/34 (6%) * |
6/41 (15%) * |
8/75 (11%)* |
| Incidence of Requirement for Post-Op Medications to Treat TN |
45/77 (58%) ** |
8/34 (24%) |
21/41 (51%) |
29/75 (39%) |
| Incidence of Post-operative Relapse |
8/83 (10%) |
4/37 (11%) |
4/43 (9%) |
8/75 (10%) |
| Incidence of need to have re- operation |
22/78 (28%) |
3/34 (9%) * |
2/42 (5%) * |
5/76 (7%) |
| Time Until Relapse (Months) |
12.1 ± 3.1 |
10.6 ± 8.5 |
6.3 ± 1.2 |
8.4 ± 4.1 |
| Number of Patients Lost to Follow-up (%) |
7/82 (9%) |
5/37 (14%) |
4/43 (9%) |
9/80 (11%) |
|
* P < 0.05 compared to BA ** P < 0.05 compared to MVD All data reported as mean ± SEM Combined = Microvascular Decompression with or without Rhizotomy | ||||
Jellish et al. Head & Face Medicine 2008 4:11 doi:10.1186/1746-160X-4-11 |
||||